The Hunter Williams Podcast GLP-1s and Anhedonia | Do GLPs Cause Emotional Blunting?
4 snips
Jan 6, 2026 Explore the intriguing relationship between GLP-1 agonists and anhedonia, a condition that causes emotional blunting. Discover how these weight-loss drugs can paradoxically dampen motivation while alleviating cravings. Learn about the brain regions involved and the potential psychiatric risks associated with different GLP-1 medications. Find practical strategies to mitigate symptoms, like journaling and lifestyle adjustments. This deep dive reveals both the benefits and the unexpected challenges of these groundbreaking therapies.
AI Snips
Chapters
Transcript
Episode notes
Holiday Meals Felt Less Compulsive
- Hunter Williams describes enjoying holiday meals but not overeating while on low-dose retatrutide.
- He still enjoyed food but didn't get the same excitement from eating a large amount.
Brain Penetration Varies By Drug
- Brain penetration differs across GLP-1 drugs and influences central effects.
- Semaglutide enters the brain readily and may carry higher risk of CNS side effects like apathy.
Real-World Data Shows Psychiatric Signals
- Real-world analyses and case reports link GLP-1s to mood events including depression and suicidal ideation.
- Hunter cites an EU analysis and a 195% higher risk of new-onset major depression in a 2024 cohort.